Cardizem is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Direct_rx. The primary component is Diltiazem Hydrochloride.
| Product ID | 72189-409_f1ea85b2-ecd3-5867-e053-2a95a90a24dc |
| NDC | 72189-409 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cardizem |
| Generic Name | Diltiazem Hcl Er |
| Dosage Form | Capsule, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2023-01-10 |
| Marketing Category | ANDA / |
| Application Number | ANDA208783 |
| Labeler Name | Direct_Rx |
| Substance Name | DILTIAZEM HYDROCHLORIDE |
| Active Ingredient Strength | 300 mg/1 |
| Pharm Classes | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2024-12-31 |
| Marketing Start Date | 2023-01-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0187-0771 | Cardizem | Diltiazem Hydrochloride |
| 0187-0772 | Cardizem | Diltiazem Hydrochloride |
| 0187-0792 | Cardizem | Diltiazem Hydrochloride |
| 72189-409 | Cardizem | Diltiazem HCL ER |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CARDIZEM 73633651 1444842 Live/Registered |
MARION LABORATORIES, INC. 1986-12-04 |
![]() CARDIZEM 73293970 1246194 Live/Registered |
Marion Laboratories, Inc. 1981-01-22 |